Anchiano Therapeutics Ltd.

Home » Anchiano Therapeutics Ltd.

IPO

Anchiano Therapeutics Ltd.

We are a clinical-stage biotechnology company committed to engineering a targeted gene therapy to improve the standard treatment for early-stage bladder cancer, which is one of the most prevalent forms of cancer.

Symbol

ANCN

Price Range
$14.55 - $14.55

Final Shares
2,400,000

Effective Date
February 12, 2019

Underwriters
Oppenheimer & Co., Ladenburg Thalmann

To view the prospectus for Anchiano Therapeutics Ltd. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253